Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Telebrands to pay $515,000 to settle multi-state suit involving Whisper XL false claims.

This article was originally published in The Gray Sheet

Executive Summary

TELEBRANDS TO PAY $515,000 TO SETTLE CONSUMER FRAUD SUIT brought by 17 state's attorney generals involving the sale and advertisement of the firm's Whisper XL hearing enhancement device. Under the terms of consent judgments filed in all 17 states July 30, Fairfield, New Jersey-based Telebrands agrees to pay a total of $515,000 in penalties and costs to the states and to refrain from selling or advertising the Whisper until it receives marketing approval for the device from FDA.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006532

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel